MD with 20+ years of experience building and leading Clinical and Medical Affairs teams to support the clinical development and launch of novel diagnostics and therapeutics across small and large companies.
I-Zu is Tesseract’s Head of Medical Affairs. Prior to joining Tesseract, I-Zu was Sr. Group Medical Director, Medical Affairs at GRAIL, where she was responsible for overseeing Medical Affairs MSL field, publication, medical education, medical information, and investigator-initiated trial functions in support of the launch of GRAIL’s first multi-cancer early detection test (GalleriTM). Her more than 20+ years of industry experience encompasses Medical Affairs, Clinical Development, Clinical Operations, Medical Information, and Drug Safety, advancing and launching innovative devices, tests, and therapies for treating serious diseases with high unmet medical need across multiple therapeutic areas. Prior to GRAIL, I-Zu served as Executive Medical Director, Medical Affairs at Jazz Pharmaceuticals and Affymax Inc. and as VP of Clinical Development and Operations at Relypsa Inc. I-Zu holds a BS in Chemistry from the University of North Carolina at Chapel Hill and a MD from the University of North Carolina at Chapel Hill School of Medicine. I-Zu is an author on numerous peer-reviewed publications and holds a number of patents.